Estrogen use and early onset Alzheimer's disease: A population-based study

Journal of Neurology Neurosurgery and Psychiatry

Volumn 67, Issue 6, 1999, Pages 779-781

  Slooter, Arjen J C ^a,b,d   Bronzova, Juliana ^a   Witteman, Jaqueline C M ^a   Van Broeckhoven, Christine ^c   Hofman, Albert ^a   Van Duijn, Cornelia M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Alzheimer's disease; Dementia; Estrogen

Indexed keywords

ESTROGEN;

ADULT; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DRUG USE; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; RELATIVE; RISK FACTOR;

EID: 0032702780     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.67.6.779     Document Type: Article

References (23)

1. Yaffe K, Sawaya G, Lieberburg I, et al. Estrogen therapy in postmenopausal women. Effects on cognitive function and dementia. JAMA 1998;279:688-95.
2. Slooter AJC, van Duijn CM. Genetic epidemiology of Alzheimer disease. Epidemiol Rev 1997;19:107-19.
3. Van Duijn CM, Hofman A. Relation between nicotine intake and Alzheimer's disease. BMJ 1991;302:1491-4.
4. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984;34:939-44.
5. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-72.
6. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatric Soc 1975;23:433-41.
7. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-7.
8. Van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-8.
9. Van Duijn CM, Tanja TA, Haaxma R, et al. Head trauma and the risk of Alzheimer's disease. Am J Epidemiol 1992;135:775-82.
10. Van Duijn CM, de Knijff P, Wehnert A, et al. The apolipoprotein E ε2 allele is associated with an increased risk of early-onset Alzheimer's disease and reduced survival. Ann Neurol 1996;37:605-10.
11. Clayton D, Hills M. Statistical models in epidemiology. Oxford: Oxford University Press, 1995:290-7.
12. Diggle PJ, Liang K-Y, Zeger SL. Analysis of longitudinal data. Oxford: Oxford University Press, 1996:137-42.
13. Hartmann BW, Huber JC. The mythology of hormone replacement therapy. Br J Obstet Gynaecol 1997;104:163-8.
14. Stampfer MJ, Colditz GA, Willett VTC, et al. Postmenopausal estrogen therapy and cardiovascular disease: 10 year follow up from the nurses' health study. N Engl J Med 1991;325:756-62.
15. Ohkura T, Teshima Y, Isse K, et al. Estrogen increases cerebral and cerebellar blood flow in postmenopausal women. Menopause 1994;2:13-8.
16. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-4.
17. Henderson VW. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 1997;48(suppl 7):S27-35.
18. Miranda RC, Sohrabji F, Toran-Allerand CD. Interactions of estrogens with the neutrophins and their receptors during neural development. Horm Behav 1994;28:367-75.
19. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985;89:484-90.
20. Goodman Y, Bruce AJ, Cheng B, et al. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity of hippocampal neurons. J Neurochem 1996;66:1836-44
21. Waring SC, Rocca WA, Petersen RC, et al. Postmenopausal estrogen replacement therapy and the risk of AD: a population-based study. Neurology 1999;52:965-70.
22. Tang M-X, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-32.
23. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology 1997;48:1517-21.